These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 24844438)

  • 1. Palmitoylethanolamide in CNS health and disease.
    Mattace Raso G; Russo R; Calignano A; Meli R
    Pharmacol Res; 2014 Aug; 86():32-41. PubMed ID: 24844438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective properties of peroxisome proliferator-activated receptor alpha (PPARα) and its lipid ligands.
    Fidaleo M; Fanelli F; Ceru MP; Moreno S
    Curr Med Chem; 2014; 21(24):2803-21. PubMed ID: 24606520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution.
    Skaper SD; Facci L; Barbierato M; Zusso M; Bruschetta G; Impellizzeri D; Cuzzocrea S; Giusti P
    Mol Neurobiol; 2015 Oct; 52(2):1034-42. PubMed ID: 26055231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palmitoylethanolamide stimulation induces allopregnanolone synthesis in C6 Cells and primary astrocytes: involvement of peroxisome-proliferator activated receptor-α.
    Raso GM; Esposito E; Vitiello S; Iacono A; Santoro A; D'Agostino G; Sasso O; Russo R; Piazza PV; Calignano A; Meli R
    J Neuroendocrinol; 2011 Jul; 23(7):591-600. PubMed ID: 21554431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harnessing the anti-inflammatory potential of palmitoylethanolamide.
    Alhouayek M; Muccioli GG
    Drug Discov Today; 2014 Oct; 19(10):1632-9. PubMed ID: 24952959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palmitoylethanolamide is a new possible pharmacological treatment for the inflammation associated with trauma.
    Esposito E; Cuzzocrea S
    Mini Rev Med Chem; 2013 Feb; 13(2):237-55. PubMed ID: 22697514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neuroprotective effects of micronized PEA (PEA-m) formulation on diabetic peripheral neuropathy in mice.
    Impellizzeri D; Peritore AF; Cordaro M; Gugliandolo E; Siracusa R; Crupi R; D'Amico R; Fusco R; Evangelista M; Cuzzocrea S; Di Paola R
    FASEB J; 2019 Oct; 33(10):11364-11380. PubMed ID: 31344333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palmitoylethanolamide in homeostatic and traumatic central nervous system injuries.
    Esposito E; Cuzzocrea S
    CNS Neurol Disord Drug Targets; 2013 Feb; 12(1):55-61. PubMed ID: 23394520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma.
    Paterniti I; Impellizzeri D; Crupi R; Morabito R; Campolo M; Esposito E; Cuzzocrea S
    J Neuroinflammation; 2013 Feb; 10():20. PubMed ID: 23374874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel composite formulation of palmitoylethanolamide and quercetin decreases inflammation and relieves pain in inflammatory and osteoarthritic pain models.
    Britti D; Crupi R; Impellizzeri D; Gugliandolo E; Fusco R; Schievano C; Morittu VM; Evangelista M; Di Paola R; Cuzzocrea S
    BMC Vet Res; 2017 Aug; 13(1):229. PubMed ID: 28768536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palmitoylethanolamide protects dentate gyrus granule cells via peroxisome proliferator-activated receptor-α.
    Koch M; Kreutz S; Böttger C; Benz A; Maronde E; Ghadban C; Korf HW; Dehghani F
    Neurotox Res; 2011 Feb; 19(2):330-40. PubMed ID: 20221904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palmitoylethanolamide protects mice against 6-OHDA-induced neurotoxicity and endoplasmic reticulum stress: In vivo and in vitro evidence.
    Avagliano C; Russo R; De Caro C; Cristiano C; La Rana G; Piegari G; Paciello O; Citraro R; Russo E; De Sarro G; Meli R; Mattace Raso G; Calignano A
    Pharmacol Res; 2016 Nov; 113(Pt A):276-289. PubMed ID: 27616549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroglial roots of neurodegenerative diseases: therapeutic potential of palmitoylethanolamide in models of Alzheimer's disease.
    Scuderi C; Steardo L
    CNS Neurol Disord Drug Targets; 2013 Feb; 12(1):62-9. PubMed ID: 23394526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palmitoylethanolamide counteracts autistic-like behaviours in BTBR T+tf/J mice: Contribution of central and peripheral mechanisms.
    Cristiano C; Pirozzi C; Coretti L; Cavaliere G; Lama A; Russo R; Lembo F; Mollica MP; Meli R; Calignano A; Mattace Raso G
    Brain Behav Immun; 2018 Nov; 74():166-175. PubMed ID: 30193877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central administration of palmitoylethanolamide reduces hyperalgesia in mice via inhibition of NF-kappaB nuclear signalling in dorsal root ganglia.
    D'Agostino G; La Rana G; Russo R; Sasso O; Iacono A; Esposito E; Mattace Raso G; Cuzzocrea S; Loverme J; Piomelli D; Meli R; Calignano A
    Eur J Pharmacol; 2009 Jun; 613(1-3):54-9. PubMed ID: 19386271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glia and mast cells as targets for palmitoylethanolamide, an anti-inflammatory and neuroprotective lipid mediator.
    Skaper SD; Facci L; Giusti P
    Mol Neurobiol; 2013 Oct; 48(2):340-52. PubMed ID: 23813098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The search for the palmitoylethanolamide receptor.
    LoVerme J; La Rana G; Russo R; Calignano A; Piomelli D
    Life Sci; 2005 Aug; 77(14):1685-98. PubMed ID: 15963531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α.
    Scuderi C; Valenza M; Stecca C; Esposito G; Carratù MR; Steardo L
    J Neuroinflammation; 2012 Mar; 9():49. PubMed ID: 22405189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palmitoylethanolamide and Its Biobehavioral Correlates in Autism Spectrum Disorder: A Systematic Review of Human and Animal Evidence.
    Colizzi M; Bortoletto R; Costa R; Zoccante L
    Nutrients; 2021 Apr; 13(4):. PubMed ID: 33919499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-Palmitoylethanolamine-Oxazoline as a New Therapeutic Strategy to Control Neuroinflammation: Neuroprotective Effects in Experimental Models of Spinal Cord and Brain Injury.
    Impellizzeri D; Cordaro M; Bruschetta G; Siracusa R; Crupi R; Esposito E; Cuzzocrea S
    J Neurotrauma; 2017 Sep; 34(18):2609-2623. PubMed ID: 28095731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.